news

• 18 Minutes with Zelira Therapeutics – 180 Markets
  12/21/2020
• Cantor Fitzgerald Hosts Fireside Chat with Zelira Therapeutics
  10/19/2020
• Zelira Therapeutics launches Zenivol™ product in Australia after TGA adds to Special Access Scheme
  09/16/2020
• Medicinal cannabis trial could help retired AFL players manage chronic pain
  09/15/2020
• Sequoia Initiation Strong Buy, 19 August 2020
  08/19/2020
• Proactive – Three medical cannabis companies in focus at Proactive’s webinar on August 11
  08/07/2020
• Proactive – Zelira Therapeutics dose escalation trial for chronic pain meets safety and efficacy endpoints
  07/14/2020
• Stockhead – Pot stock Zelira Therapeutics successfully passes another Phase I clinical trial
  07/14/2020
• Zelira’s Oludare Odumosu, Managing Director USA speaking at More Than A Moment virtual event
  06/26/2020
• Dr Richard Hopkins, Zelira Therapeutics – 3AW Chronic Pain Interview
  06/18/2020
• 9 Today – Sleep Drug Jackpot: Is Cannabis oil the answer to insomnia?
  06/01/2020
• Zelira’s Dr Richard Hopkins, Managing Director – ex USA will be presenting on the 2 June, 2pm AEST at the 2020 Finance News Network CEO Showcases
  05/30/2020
• Benzinga Article: A Medicinal Cannabis Company That’s Conducting Clinical Research On Autism, Insomnia, And More
  05/28/2020
• Dr Richard Hopkins, Zelira Therapeutics – Triple M Great Southern WA
  05/26/2020
• Cannaweek Podcast, 05 May 2020
  05/18/2020